Symatix – Synthetic Amniotic Membrane
We are developing an innovative synthetic amniotic membrane substitute. Click here to find out more.
Integrated Risk Management in Biomaterials Design and Manufacture
The Electrospinning Company was invited into the BIORIMA European H2020 funded project as an industrial partner due to their experience in the design, development, and manufacture of nanoscale biomaterials. As a member of the BIORIMA consortium, The Electrospinning Company contributed to the development of the Integrated Risk Management (IRM) framework and is now applying it… Read more »
Electrospinning in Orthopaedics
Read this article where we explore the use of electrospun materials in Orthopaedics.
£4.5M Investment Led by Confluent Medical
Proceeds to be used to expand electrospinning capabilities & capacity, driving company growth Harwell, UK, May 4 2021 – The Electrospinning Company (Electrospinning), a leader in the development and manufacture of nanofibrous biomaterials for use in tissue regenerative devices, has completed a £4.5m ($6.3m) fundraising round, led by US materials science company Confluent Medical Technologies Inc. (Confluent) as a strategic investor…. Read more »
Corneal Case Study
Read how close partnership with our client helped overcome technological & pandemic challenges.
EUROPCR – 20-23 May 2025 – Paris, France
Learn more about Caladrix coatings for metal and non-metal implantable devices.
Medica/Compamed – Nov 11-13 2024 – Dusseldorf
Meet Ann Kramer on 12th November or find out more from Eoghan Mulrooney on the Avem Market Solutions stand L20 in Hall 8B.
The Electrospinning Company and Avem Market Solutions partner to bring Electrospinning’s biomaterials to the medical device industry.
The Electrospinning Company, a leading innovator in nanofibrous biomaterials for medical devices, has announced a strategic partnership with Avem Market Solutions to bring its advanced products to a broader range of medical device customers. This collaboration will combine Electrospinning’s cutting-edge biomaterials with Avem’s deep industry expertise to accelerate the development and commercialisation of differentiated medical… Read more »
An R&D Scientist Intern’s Journey at The Electrospinning Company
Maria is currently pursuing a Bachelor of Science degree in Biochemistry at the University of Bath. During her year in industry, she has been working as an R&D Scientist Intern at The Electrospinning Company, with a focus on our Caladrix® Technology coatings platform. Maria’s Role Maria has been part of the team in developing novel… Read more »
An R&D Engineering Intern’s Journey at The Electrospinning Company
Tyla is currently pursuing a Bachelor of Engineering degree in Bioengineering at Loughborough University. During her year in industry, she has been working as an R&D Engineering Intern at The Electrospinning Company. Through this placement she has gained invaluable knowledge and experience in biomaterials, which will support her future studies. Tyla’s Role As an R&D… Read more »
AAOS 2024, 13-15 February San Francisco
The Electrospinning Company will once again exhibit at the AAOS 2024 in San Francisco, US, from 13th to 15th of February. You are welcome to visit our booth #864 and find out more about our innovative technology. Our CEO, Ann Kramer, Sen. Director of Bus. Dev. North America Jeff Orosco, Head of Business Development, Marco… Read more »
Congratulations Dr. Sahay!
We congratulate Dr. Priti Sahay (right) from the University of Nottingham with winning the David Meyer Research Price 2024. Dr. Sahay presented her work on our Symatix Membrane at the The European Vision & Eye Research Association 2023 and Nottingham Eye Symposium. Her work is published in Acta Ophthalmologica and can be found here About… Read more »
Biosynthetic Soft Tissue Regeneration Membrane
The Electrospinning Company is excited to announce the development of the second Symatix Technology material. Next to our Symatix Membrane, the world’s first amniotic membrane substitute for ocular surface regeneration, we have started development of a proprietary membrane for use in soft tissue regeneration. The membrane comprises of a synthetic nonwoven structure enriched by medical… Read more »
AWRE 2024, 31 Jan – Feb 1 Ghent, Belgium
The Electrospinning Company will be attending the AWRE 2024 in Ghent, Belgium, between the 31st and 1st of February. Our Head of Business Development, Marco Thio, and Senior Scientist Giulia Creed are glad to share their insights into non-woven solutions in abdominal wall reconstruction using electrospinning technology. Book a meeting with them at: info@electrospinning.co.uk
MD&M West 2024, February 6-8 Anaheim, USA
The Electrospinning team will be at Confluent Medical Technologies booth #1812 February 6-8, 2024, to talk about the latest on our Caladrix technology, our products and electrospinning technology. For more information visit the Confluent Medical Technologies website.
Medica 2023, Düsseldorf – Germany 13-16 November 2023
The Electrospinning Company will attend Medica 2023 in Düsseldorf – Germany from 13 to 16 November 2023. Katrina Moisley, Nanayaa Bates and Conan Campbell are delighted to meet you talking about the latest on our stent cover technology and our innovative electrospinning method. For more information about our recent collaboration and successes please follow this… Read more »
